URL details: www.opdivogastroeso.com/adjuvant-EC-GEJC-efficacy
URL title:
OPDIVO® (nivolumab) Efficacy Data for the Adjuvant Treatment of ESO and GEJ Cancers
URL description:
View efficacy information for OPDIVO® (nivolumab) for the adjuvant treatment of completely resected ESO or GEJ cancer. Please see Indications and Important Safety Information.
URL last crawled:
2023-01-04
URL speed:
0.475 MB/s,
downloaded in 0.400 seconds
4 external links to this url
Only links from external domains are shown on this page.
found date
link text
from url
2022-09-14
Adjuvant Treatment of Completely Resected ESO or GEJ Cancer
2022-08-31
Adjuvant Treatment of Completely Resected ESO or GEJ Cancer
2022-07-22
Adjuvant Treatment of Completely Resected ESO or GEJ Cancer
2022-07-18
Adjuvant Treatment of Completely Resected ESO or GEJ Cancer